Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Schweighoffer

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
European Journal of Immunology|November 1, 1996
Tumor cells expressing a recall antigen are powerful cancer vaccinesT Schweighoffer
Pathology Oncology Research : POR|May 13, 2008
Molecular cancer vaccines: Tumor therapy using antigen-specific immunizationsT Schweighoffer
Current Opinion in Cell Biology|October 1, 1992
Adhesion cascades: diversity through combinatorial strategiesT Schweighoffer, S Shaw
Blood|July 1, 1989
Helper and suppressor T-cell function in HIV-infected hemophilia patientsR Weimer, T Schweighoffer, K Schimpf, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 1999
CD44-deficient mice develop normally with changes in subpopulations and recirculation of lymphocyte subsetsU Protin, T Schweighoffer, W Jochum, et al.
Cell Adhesion and Communication|October 1, 1994
Differential expression of integrins alpha 6 and alpha 4 determines pathways in human peripheral CD4+ T cell differentiationT Schweighoffer, G E Luce, Y Tanaka, et al.
Gene Therapy|September 1, 1996
Depletion of naive T cells of the peripheral lymph nodes abrogates systemic antitumor protection conferred by IL-2 secreting cancer vaccinesT Schweighoffer, W Schmidt, M Buschle, et al.
Gene Therapy|April 22, 2003
In vivo plasmid DNA electroporation generates exceptionally high levels of epitope-specific CD8+ T-cell responsesW Paster, M Zehetner, M Kalat, et al.
Cytokines and Molecular Therapy|September 1, 1996
Adenovirus-enhanced receptor-mediated transferrinfection for the generation of tumor vaccinesT Schweighoffer, M Berger, M Buschle, et al.
Allergy|March 27, 2010
A granular variant of CD63 is a regulator of repeated human mast cell degranulationThorsten Schäfer, P Starkl, C Allard, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
European Journal of Immunology|November 1, 1996
Tumor cells expressing a recall antigen are powerful cancer vaccinesT Schweighoffer
Pathology Oncology Research : POR|May 13, 2008
Molecular cancer vaccines: Tumor therapy using antigen-specific immunizationsT Schweighoffer
Current Opinion in Cell Biology|October 1, 1992
Adhesion cascades: diversity through combinatorial strategiesT Schweighoffer, S Shaw
Blood|July 1, 1989
Helper and suppressor T-cell function in HIV-infected hemophilia patientsR Weimer, T Schweighoffer, K Schimpf, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 1999
CD44-deficient mice develop normally with changes in subpopulations and recirculation of lymphocyte subsetsU Protin, T Schweighoffer, W Jochum, et al.
Cell Adhesion and Communication|October 1, 1994
Differential expression of integrins alpha 6 and alpha 4 determines pathways in human peripheral CD4+ T cell differentiationT Schweighoffer, G E Luce, Y Tanaka, et al.
Gene Therapy|September 1, 1996
Depletion of naive T cells of the peripheral lymph nodes abrogates systemic antitumor protection conferred by IL-2 secreting cancer vaccinesT Schweighoffer, W Schmidt, M Buschle, et al.
Gene Therapy|April 22, 2003
In vivo plasmid DNA electroporation generates exceptionally high levels of epitope-specific CD8+ T-cell responsesW Paster, M Zehetner, M Kalat, et al.
Cytokines and Molecular Therapy|September 1, 1996
Adenovirus-enhanced receptor-mediated transferrinfection for the generation of tumor vaccinesT Schweighoffer, M Berger, M Buschle, et al.
Allergy|March 27, 2010
A granular variant of CD63 is a regulator of repeated human mast cell degranulationThorsten Schäfer, P Starkl, C Allard, et al.
Pageof 3